Day: October 27, 2021

iCoreConnect now has 23 state association partners and over 70 agreements with state or regional healthcare associations WINDERMERE, FL, Oct. 27, 2021 (GLOBE NEWSWIRE) — iCoreConnect, Inc. (OTCQB: ICCT), a cloud-based, Software-as-a-Service (SaaS) platform for healthcare business workflow, today announced the expansion of its endorsed products by the Michigan Dental Association (MDA).  MDA added five new product endorsements, bringing the total number of endorsed iCoreConnect products to seven. The expansion includes: iCoreVerify automatic insurance verification,  iCoreHuddle practice revenue dashboard, iCoreCloud automatic HIPAA-compliant cloud back up, iCoreIT Managed Services, iCoreDental cloud-based practice management software.   The relationship between iCoreConnect and the Michigan Dental Association dates to 2018, when...

Further enhances patient experience with Epic EHR and MyChart AUSTIN, Texas, Oct. 27, 2021 (GLOBE NEWSWIRE) — Phunware, Inc. (NASDAQ: PHUN) (the “Company”), a fully-integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands worldwide, announced today that after successfully completing Epic’s comprehensive integration process, its mobile Digital Front Door solution for healthcare is now available on the Epic App Orchard marketplace. Phunware’s Multiscreen-as-a-Service (MaaS) Digital Front Door enables hospital systems and clinicians to contextually engage their patients and visitors on mobile, all while providing optimal care, driving operational efficiency and ensuring patient satisfaction. ”With almost a third of the Electronic Health Record (EHR) market and more than...

Vancouver, British Columbia, Oct. 27, 2021 (GLOBE NEWSWIRE) — St. James Gold Corp. (the “Company”) (TSXV: LORD) (OTCQB: LRDJF) (FSE: BVU3) is pleased to provide a corporate update on its activities for 2021. Highlights:Completion of 2021 drill exploration program on its Florin Gold Project in the Yukon Territory Successful capital financings of $10,000,000 Expansion of stock listing in the FSE and OTCQB markets Successful DTC listing on the OTC market Commencement of work exploration activities on its Newfoundland claimsFollowing the successful participation of last week’s New Orleans Gold Conference, one of the first large scale in person conferences of its kind in the past 20 months. The Company is awaiting the core drill sample results of its recently completed field season drill program at the Florin Gold Project in the...

ABVC BioPharma Receives Taiwan Regulatory Approval for ABV-1505 ADHD Phase II Part 2 Clinical Study Completion of the Study Expected by the End of 2022 FREMONT, CA, Oct. 27, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced it received Taiwan Central Institutional Review Board (CIRB) approval to begin a Phase II Part 2 study of its ABV-1505 Attention-Deficit Hyperactivity Disorder (ADHD) drug at five prestigious medical centers in Taiwan.  The Part 2 study is a randomized, double-blind, placebo-controlled study involving a total of approximately 100 patients in Taiwan.  ABVC is also waiting for approval to conduct part of the study in the United States at the University...

Tingo Mobile Plc partners with Visa as its sole card scheme NEW YORK, Oct. 27, 2021 (GLOBE NEWSWIRE) — via InvestorWire — To further deepen its financial services in Nigeria and with ambitious expansions plans across Africa in the coming years, Tingo Mobile Plc (OTC: IWBB) (the “Company”) today announces it has entered into an agreement with Visa Inc. (NYSE: V), the world leader in digital payments. Tingo is a leading Agri-Fintech business in Africa and has delivered significant impact with its unique rural communities-based business model. The Company’s goal is to become Africa’s leading Agri-Fintech business, delivering significant social impact to many rural communities and providing a unique platform to enable financial inclusion, social upliftment, wealth creation and a sophisticated marketplace to promote its produce...

CAMBRIDGE, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report third quarter 2021 financial results after the Nasdaq Global Market closes on Wednesday, November 3, 2021. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discuss its third quarter 2021 financial results and to provide a corporate update. The conference call may be accessed by dialing (844) 534-7313 for domestic callers and (574) 990-1451 for international callers. The passcode for the call is 7131019. Please specify to the operator that you would like to join the “Sarepta Third Quarter 2021 Earnings Call.” The conference call will be webcast live under the investor relations section of Sarepta.com and will be archived there following...

300MW Renewable hydrogen production Sites to Start operation in 2025 and an initiative Seeks to start the development of a 1GW production site LATHAM, N.Y. and NANTES, France, Oct. 27, 2021 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ : PLUG), a leading provider of turnkey hydrogen solutions for the global green hydrogen economy, and Lhyfe, a pioneer producer and supplier of renewable and ecological hydrogen, today announced an partnership to jointly pursue and develop green hydrogen generation plants throughout Europe. The initiative seeks to generate a total hydrogen capacity of 300MW by 2025, and to start the development of a 1GW production site. The agreement builds upon the working relationship already established between the two companies earlier this year. In that project, Plug Power’s hydrogen electrolyzer technology will...

Agreement Provides for Option to License Alzheimer’s Therapeutic Englewood Cliffs, NJ, Oct. 27, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO), a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announced that it has entered into a sponsored research agreement with Columbia University pursuant to which Silo has been granted an option to license certain assets currently under development, including Alzheimer’s disease. This agreement incorporates the work of Dr. Christine Ann Denny, an Associate Professor of Clinical Neurobiology (in Psychiatry) at Columbia University Irving Medical Center. Denny and her team are focusing their efforts on the molecular mechanisms underlying learning and memory, including diseases such as Alzheimer’s disease. An estimated 5.8 million...

COLDWATER, Mich., Oct. 27, 2021 (GLOBE NEWSWIRE) — Southern Michigan Bancorp, Inc. (OTC Pink: SOMC) announced third quarter 2021 net income of $3,138,000, or $0.69 per share, compared to net income of $2,018,000, or $0.44 per share, for the third quarter of 2020. Southern earned $9,235,000, or $2.02 per share, for the nine-month period ending September 30, 2021 compared to $5,362,000, or $1.17 per share, for the same nine-month period a year ago.    John H. Castle, Chairman and Chief Executive Officer of Southern Michigan Bancorp, Inc. stated, “During the third quarter Southern continued to capitalize on market opportunities presented to us. We are pleased to report continued loan and deposit growth during the quarter, with additional growth expected during the fourth quarter. Earnings through the third quarter now exceed our 2019...